The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Mullard, A. 2014 FDA drug approvals. Nat Rev Drug Discov 14, 77–81 (2015). https://doi.org/10.1038/nrd4545
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4545
- Springer Nature Limited
This article is cited by
-
Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
Signal Transduction and Targeted Therapy (2020)
-
When will clinical trials finally reflect diversity?
Nature (2018)
-
Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53–MDM2 Interaction Useful in Targeted Cancer Therapy
Topics in Current Chemistry (2017)
-
High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model
Stem Cell Reviews and Reports (2017)
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine (2016)